Individual Investor

Martin Edwards

Signal active

Bio

N/A

Location

N/A

Social

Primary Organization

N/A

Jobs history

N/A

Board and Advisor Roles

N/A

Invest in regions

Recommendation from your interest

Vikas Sinha

Chief Financial Officer

Mark W. Hahn

Chief Financial Officer

David Ebsworth

No designation

Anders Ullman

Non Executive Director

David Zaccardelli

President and Chief Executive Officer

Investment portfolio

Martin Edwards has made 1 investments. Their Latest investment was Post-IPO Equity - Verona Pharma on Jul 17, 2020

Personal investment

Annouced Date	Organization Name	Funding Round	Money Raised
Jul 17, 2020	Verona Pharma	Post-IPO Equity - Verona Pharma	200.0M

Partner investment

Annouced Date	Organization Name	Funding Round	Investor Name	Money Raised
Aug 21, 2006	Thiakis	Series A - Thiakis	Novo Ventures	19.0M
Dec 19, 2012	NeRRe Therapeutics	Series A - NeRRe Therapeutics	Novo Holdings	18.4M
Jul 22, 2015	KalVista Pharmaceuticals	Series B - KalVista Pharmaceuticals	Novo Holdings	33.0M
Jan 05, 2017	NeRRe Therapeutics	Series B - NeRRe Therapeutics	Novo Holdings	28.6M

Exits

Verona Pharma

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory dis...

Invest in industries

N/A

Recent Activity

There is no recent news or activity for this profile.